Page 11 of 27

PA27.12-13 | Cystic Kidney Disease, Renal Stones & Obstructive Uropathy — SDL Guide (Part 3)

Hydronephrosis — Morphology and Grades

Four-stage diagram showing progressive hydronephrosis from mild pelvic dilation to an end-stage thin-walled fluid-filled kidney with severe cortical loss.

Morphological Grades of Hydronephrosis

Panel A: Stage 1 mild hydronephrosis: mild renal pelvic dilation, intact calyces, intact papillae, normal renal cortex 10-12 mm, preserved GFR.. Panel B: Stage 2 moderate hydronephrosis: dilated calyces, papillary blunting, early papillary atrophy, mild cortical thinning, mildly reduced GFR.. Panel C: Stage 3 severe hydronephrosis: marked pelvicalyceal dilation, papillary atrophy, significant cortical thinning, markedly reduced GFR.. Panel D: Stage 4 end-stage hydronephrosis: thin-walled hydronephrotic sac, fluid-filled renal pelvis and calyces, cortex reduced to 1-2 mm rim, fibrous replacement, minimal or absent GFR.. Bottom inset: Microscopic progression: tubular dilation, tubular atrophy, interstitial fibrosis, late global glomerulosclerosis..

Morphological appearance:

Gross: The renal pelvis and calyces are progressively dilated. In early obstruction, only the pelvis is dilated (pelvicaliectasis). In advanced disease, the kidney is converted into a large, thin-walled sac of fluid — the cortex is reduced to a thin rim.

Cut section shows:
- Dilation of calyces → blunting of papillae → progressive papillary atrophy.
- Cortical thinning (normal cortex ~10–12 mm; advanced hydronephrosis may reduce this to 1–2 mm).
- In complete obstruction, the parenchyma is entirely replaced by fibrous tissue and fluid.

Microscopy: Tubular dilation → tubular atrophy → interstitial fibrosis → glomeruli initially spared then globally sclerosed in late stages.

Four-panel progression of hydronephrosis from mild pelvic dilation to end-stage thin-walled hydronephrotic sac, with residual cortex, relative GFR, and major complications shown.

Progression and Complications of Hydronephrosis

Panel A: Stage 1 mild hydronephrosis: mild renal pelvic dilation, intact papillae, normal renal cortex, renal medulla, calyces, ureter, residual cortex >90%, relative GFR normal or near normal.. Panel B: Stage 2 hydronephrosis: dilated calyces, widened renal pelvis, papillary blunting, mild cortical thinning, ureter, residual cortex 70-90%, relative GFR mildly reduced.. Panel C: Stage 3 hydronephrosis: severe pelvicalyceal dilation, flattened papillae, significant cortical thinning, compressed medulla, ureter, residual cortex 30-60%, relative GFR moderately to severely reduced.. Panel D: Stage 4 end-stage hydronephrosis: thin-walled hydronephrotic sac, minimal residual cortex, nearly absent medulla, massively dilated collecting system, ureter, residual cortex <20%, relative GFR minimal or <15%.. Panel E: Clinical consequences: UTI and pyelonephritis, pyonephrosis emergency, stone formation, AKI, CKD, hypertension from renin-angiotensin activation, post-obstructive diuresis, and biopsy inset showing tubular dilation, tubular atrophy, and interstitial fibrosis..

Complications of obstructive uropathy:
1. Urinary tract infection → pyelonephritis — stasis promotes bacterial growth; if infected → pyonephrosis (pus-filled hydronephrotic kidney) — surgical emergency.
2. Stone formation — stasis promotes nucleation and crystallisation.
3. AKI — bilateral obstruction or obstruction in a solitary functioning kidney.
4. CKD — chronic partial obstruction is a silent cause of progressive renal impairment.
5. Hypertension — activation of the renin–angiotensin system.
6. Post-obstructive diuresis — after relief of bilateral obstruction, massive salt and water diuresis; requires careful fluid and electrolyte replacement.

SELF-CHECK

A 65-year-old man with BPH presents with bilateral hydroureteronephrosis and raised serum creatinine. Biopsy of the renal cortex would most likely show:

A. Proliferative glomerulonephritis with immune complex deposits

B. Tubular dilation, tubular atrophy, and interstitial fibrosis

C. Necrotising vasculitis of arcuate arteries

D. Diffuse mesangial IgA deposition

Reveal Answer

Answer: B. Tubular dilation, tubular atrophy, and interstitial fibrosis

Obstructive uropathy from BPH causes back-pressure ischaemia and tubular injury. The histological hallmarks are tubular dilation (early) progressing to tubular atrophy and interstitial fibrosis (late) — collectively called obstructive nephropathy. Glomeruli are relatively preserved until late stages. Proliferative GN, vasculitis, and IgA nephropathy are immunologically mediated, not obstructive in mechanism.

Distinguishing ADPKD from Other Cystic Diseases — A Framework

⚑ AI image — pending faculty review (auto-QA score 6/10; best of 3 attempts)

Three-column comparison diagram distinguishing ADPKD, ARPKD, and acquired cystic kidney disease by inheritance, age of onset, kidney size, cyst distribution, and key clinical associations.

Framework for Distinguishing Cystic Kidney Diseases

Panel A: ADPKD; adult onset; autosomal dominant; PKD1/PKD2; enlarged bilateral kidneys; numerous cortical and medullary cysts; hepatic cysts; hypertension; berry aneurysm.. Panel B: ARPKD; perinatal or infantile onset; autosomal recessive; PKHD1; enlarged bilateral kidneys; collecting duct dilatation; congenital hepatic fibrosis.. Panel C: Acquired cystic disease; long-term dialysis; ESRD; small shrunken kidneys; multiple acquired cysts; increased renal cell carcinoma risk..

Examiners frequently ask you to distinguish ADPKD from ARPKD and from acquired cystic disease. Use this framework:

FeatureADPKDARPKDAcquired Cystic Disease
InheritanceAutosomal dominantAutosomal recessiveAcquired (dialysis)
GenePKD1/PKD2PKHD1Somatic
Age of onset4th–5th decadePerinatal / infantileAfter 5–10 yrs dialysis
Cyst distributionBilateral, all segmentsBilateral, collecting ductsBilateral, cortex/medulla
Cyst sizeLarge, varied (mm–cm)Tiny, radial spongeSmall–medium
Associated lesionBerry aneurysm, hepatic cysts, MVPCongenital hepatic fibrosis↑ RCC risk
ESRD timing5th–6th decadeChildhood (severe forms)Already in ESRD
Key clinical pointerFamily history, palpable kidneys, hypertension, SAHNeonate / infant, Potter sequence, portal hypertensionLong-term haemodialysis patient

Simple cortical cysts differ from all of the above: unilateral or few bilateral, large, unilocular, in adults over 50, no genetic basis, no ESRD risk.

SELF-CHECK

In the investigation of nephrolithiasis, which stone type can be dissolved medically by alkalinising the urine, and what is the agent of choice?

A. Calcium oxalate stones — thiazide diuretics reduce urinary calcium

B. Struvite stones — antibiotics eliminate urease-producing organisms

C. Uric acid stones — potassium citrate alkalinises urine above pH 6.5

D. Cystine stones — dietary protein restriction reduces cystine load

Reveal Answer

Answer: C. Uric acid stones — potassium citrate alkalinises urine above pH 6.5

Uric acid stones precipitate in acidic urine (pH <5.5) because uric acid's pKa is 5.5 — below this, the undissociated, insoluble form predominates. Raising urine pH above 6.5 with oral potassium citrate converts uric acid to the soluble urate anion, dissolving existing stones and preventing new ones. Thiazides reduce calcium excretion (useful for calcium oxalate but do not dissolve stones). Struvite stones require surgical removal and antibiotic therapy — they cannot be dissolved medically. Cystine stone management uses D-penicillamine or tiopronin to complex cystine, not diet alone.